Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

HINJ

VENDORS EVENT: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, October 23, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends in procurement and issues of importance to the industry. Continue reading

HINJ, PhRMA, Others Challenge NJ Attorney General’s Push to Limit Compensation to Prescribing Doctors

Dean J. Paranicas, President and Chief Executive Officer, HINJ

Trenton, NJ, October 23, 2017 — WHYY Public Radio Philadelphia’s Joe Hernandez reports that, in a new push to fight the opioid crisis, New Jersey officials are trying to stop the flow of legal but highly addictive painkillers at the source: doctors.

A proposed rule change by N.J. Attorney General Christopher Porrino would restrict the amount of money and other compensation drug companies can give out to doctors and other prescribers.  In doing so, state officials hope medical professionals will feel less pressure to prescribe opioids created and sold by the same companies that ply them with gifts and food.

But at a Thursday public hearing in Newark, representatives of the state’s pharmaceutical and medical industries criticized the potential rule change, questioning why it would apply to all drugs and claiming it would damage patient care and drive providers out of state. Continue reading

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center to Host Cybersecurity for Medical Devices’ on October 19; Second in Forum Series

New Brunswick, NJ, October 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) on Thursday, October 19 for “Cybersecurity for Medical Devices: Why and How,” which is the second in their Fall 2017 series of educational panels and seminars that focus on the medical device industry.

The forum will be held from 5:00 to 7:00 p.m. at Rutgers University Easton Auditorium (Busch Campus), 101 Bevier Road, Piscataway.  A networking reception will begin at 5:00 p.m.; the program will start at 5:30 p.m.

Medical device vulnerability to cybercrime is increasing, creating threats that can result in hospital data theft, patient identity theft and potential harmful impact to medical device safety and effectiveness.  Continue reading

THURSDAY MORNING! Join HINJ for 2017 Life Sciences Celebration in Trenton; Six Honorees Named

New Brunswick, NJ, October 10, 2017 ― The HealthCare Institute of New Jersey (HINJ) will honor meritorious leadership in and contributions to New Jersey’s life sciences community at HINJ’s Life Sciences Celebration 2017, which will be held Thursday, October 12 from 8:00 to 10:00 a.m. at the Historic Trenton Masonic Temple, 100 Barrack Street, Trenton.

Online registration for the free event is now open.

HINJ’s 2017 honorees are: Continue reading

R&D Council of NJ Names 2017 Edison Patent and Special Recognition Honorees; Event Set for Nov. 2

Chatham, NJ, September 28, 2017 ― The Research & Development Council of New Jersey will present its 2017 Annual Edison Patent Awards on November 2 at the Liberty Science Center in Jersey City, NJ.

The 2017 Edison Patent Award winners — which include Merck & Co., Inc. and Johnson & Johnson subsidiary Ethicon, member companies of the HealthCare Institute of New Jersey (HINJ) — are:

  • Biomaterials: Rutgers, The State University of New Jersey
  • Biomedical: New Jersey Institute of Technology (NJIT)
  • Energy: Siemens Energy
  • Environmental: BASF
  • Imaging Systems: Princeton Plasma Physical Laboratory
  • Industrial Process: ExxonMobil
  • Information Technology: Avaya
  • Instrumentation: Stevens Institute of Technology
  • Materials: Honeywell
  • Medical: Ethicon
  • Pharmaceutical: Lexicon Pharmaceuticals
  • Pharmaceutical: Merck & Co., Inc.
  • Technology Transfer: Princeton University
  • Telecommunications: Nokia Bell Labs

Continue reading

HINJ Named Among ‘Best Lobbying Firms’ in NJBIZ’s First Readers Rankings Survey

New Brunswick, NJ, September 20, 2017 — The HealthCare Institute of New Jersey (HINJ) was among the New Jersey companies, organizations and universities named in NJBIZ’s inaugural “Readers Rankings” survey.

In a special supplement published with NJBIZ’s September 18 issue, HINJ was named as one of the “Best Lobbying Firms,” along with Gibbons PC, Princeton Public Affairs Group and Public Strategies Impact LLC, with which HINJ tied for #3.

HINJ member companies Johnson & Johnson and Merck & Co., along with Rutgers University, were reader-ranked as the “Best Life Sciences Companies.” Continue reading

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center Kick Off Forum Series with ‘Innovations in 3-D Printing’ on September 19

Piscataway, NJ, September 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) for “Innovations in 3-D Printing: The Latest Technology in Industry” on Tuesday, September 19 at Rutgers’ Busch Campus in Piscataway, NJ.

The free event will be the first in Rutgers and HINJ’s Fall series of educational panels and seminars that focus on the medical device industry.

Attendees will learn the latest about 3-D printing technology and its innovative uses in pre-surgical planning, training and medical device industry applications. Continue reading

PhRMA Releases ‘Research in Your Backyard’ for New Jersey; PhRMA, HINJ and WWFH-NJ Host Discussion Focused on Biopharma Research in Garden State

New Brunswick, NJ, September 16, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) on June 28 released a new report entitled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 patients participated in clinical trials around the state in 2013, generating an estimated economic impact of $617 million.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey on June 28.

In addition to a presentation of the new PhRMA report, the event featured a panel discussion of industry experts that was moderated by HINJ President and Chief Executive Officer Dean J. Paranicas.  The panelists were: Continue reading

PhRMA’s ‘Research in Your Backyard’ for New Jersey Explores Clinical Trials’ State Impact

New Brunswick, NJ, September 15, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) on June 28 released a new report entitled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 patients participated in clinical trials around the state in 2013, generating an economic impact of $617 million.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey. Continue reading

Vendors Event: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, September 1, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends on procurement and issues of importance to the industry. Continue reading